Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases

Nature

Volumn 405, Issue 6784, 2000, Pages 354-360

  Taguchi, Akihiko ^a   Blood, David C ^a   Del Toro, Gustavo ^a   Canet, Anthony ^a   Lee, Daniel C ^a   Qu, Wu ^a   Tanjl, Nozomu ^a   Lu, Yan ^a   Lalla, Evanthia ^a   Fu, Caifeng ^a   Hofmann, Marlon A ^a   Kislinger, Thomas ^a   Ingram, Mark ^a   Lu, Amy ^a   Tanaka, Hidekazu ^b   Hori, Osamu ^c   Ogawa, Satoshi ^c   Stern, David M ^a   Schmidt, Ann Marie ^a  

^a Columbia University ^*  (United States)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^c KANAZAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PROTEIN DERIVATIVE; RECEPTOR; SYNAPTOPHYSIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CANCER INVASION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; FEMALE; MALE; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RAT; SIGNAL TRANSDUCTION; TUMOR GROWTH;

ANIMALS; BROMODEOXYURIDINE; CARRIER PROTEINS; HIGH MOBILITY GROUP PROTEINS; HMGB1 PROTEIN; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED C57BL; MICE, NUDE; MICE, SCID; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; RATS; RECEPTORS, IMMUNOLOGIC; TRANSFECTION; TUMOR CELLS, CULTURED;

ANIMALIA;

EID: 0034682315     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/35012626     Document Type: Article

References (30)

1. Schmidt, A. M. et al. Isolation and characterization of binding proteins for advanced glycosylation endproducts from lung tissue which are present on the endothelial cell surface. J. Biol. Chem. 267, 14987-14997 (1992).
2. Neeper, M. et al. Cloning and expression of RAGE: a cell surface receptor for advanced glycosylation end products of proteins. J. Biol. Chem. 267, 14998-15004 (1992).
3. Hori, O. et al. The receptor for advanced glycation endproducts (RAGE) is a cellular binding site for amphoterin: mediation of neurite outgrowth and coexpression of RAGE and amphoterin in the developing nervous system. J. Biol. Chem. 270, 25752-25761 (1995).
4. Wautier, J.-L et al. Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy: soluble receptor for advanced glycation endproducts blocks hyperpermeability. J. Clin. Invest. 97, 238-243 (1996).
5. Park, L. et al. Suppression of accelerated diabetic atherosclerosis by soluble receptor for AGE(sRAGE). Nature Med. 4,1025-1031 (1998).
6. Yan, S. D. et al. RAGE and amyloid beta peptide neurotoxicity in Alzheimer's disease. Nature 382, 685-691 (1996).
7. Yan, S. D. et al. Amyloid-beta peptide-RAGE interaction elicits neuronal expression of M-CSF: a proinflammatory pathway in Alzheimer's disease. Proc. Natl Acad. Sci. USA 94, 5296-5301 (1997).
8. Hofmann, M. A. et al. RAGE mediates a novel pro inflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell 97, 889-901 (1999).
9. Yan, S.-D. et al. Enhanced cellular oxidant stress by the interaction of advanced glycation endproducts with their receptors/binding proteins. J. Biol. Chem. 269, 9889-9897 (1994).
10. Lander, H. L., Tauras, J. M. Ogiste, J. S., Moss, R. A. & Schmidt, A. M. Activation of the receptor for advanced glycation endproducts triggers a MAP kinase pathway regulated by oxidant stress. J. Biol. Chem. 272, 17810-17814 (1997).
11. Huttunen, H. J., Fages, C. & Rauvala, H. Receptor for advanced glycation endproducts [RAGE]-mediated neurite outgrowth and activation of NF-κB require the cytoplasmic domain of the receptor but different downstream signaling pathways. J. Biol. Chem. 274, 19919-19924 (1999).
12. Rauvala, H. & Pihlaskari, R. Isolation and some characteristics of an adhesive factor of brain that enhances neurite outgrowth in central neurons. J. Biol. Chem. 262, 16625-16635 (1987).
13. Rauvala, H. et al. The adhesive and neurite-promoting molecule p30: analysis of the amino-terminal sequence and production of antipeptide antibodies thai detect p30 at the surface of neuroblastoma cells and of brain neurons. J. Cell. Biol. 107, 2293-22305 (1988).
14. Parkkinen, J. & Rauvala, H. Interactions of plasminogen and tissue plasminogen activator (t-PA) with amphoterin. J. Biol. Chem. 266, 16730-16735 (1991).
15. Parkkinen, J. et al. Amphoterin, the 30-kDa protein in a family of HMG1-type polypeptides. Enhanced expression in transformed cells, leading edge localization, and interactions with plasminogen activation. J. Biol. Chem. 268,19726-19738 (1993).
16. Brunet, A. et al. Nuclear translocation of p42/p44 mitogen-activated protein kinase is required for growth factor-induced gene expression and cell cycle entry. EMBO J. 18, 664-674 (1999).
17. Tsang, D. K. & Crowe, D. L. The mitogen activated protein kinase pathway is required for proliferation but not invasion of human squamous cell carcinoma lines. Int. J. Oncol. 15, 519-523 (1999).
18. Talarmin, H. et al. The mitogen-activated protein kinase/extracellular signal-regulated kinase cascade activation is a key signalling pathway involved in the regulation of G(I) phase progression in proliferating hepatocytes. Mol. Cell. Biol. 19, 6003-6011 (1999).
19. Klemke, R. L. et al. Regulation of cell motility by mitogen-activated protein kinase. J. Cell Biol. 137, 481-492 (1997).
20. Montesano, R., Soriano, J. V., Hossseini, G., Pepper, M. S. & Schramek, H. Constitutivety active mitogen-activated protein kinase MEK1 disrupts morphogenesis and induces an invasive phenotype in Madin-Darby canine kidney epithelial cells. Cell Growth Differ. 10, 317-332 (1999).
21. Reddy, K. B., Krueger, J. S., Kondapaka, S. B. & Diglio, C. A. Mitogen-activated protein kinase (MAPK) regulates the expression of progelatinase B (MMP-9) in breast epithelial cells. Int. J. Cancer 82, 268-273 (1999).
22. Aguirre-Ghiso, J. A. et al. Ra1A requirement for v-Src- and v-Ras-induced tumorigenicity and overproduction of urokinase-type plasminogen activator: involvement of metalloproteases. Oncogene 18, 4718-4725 (1999).
23. Esparza, J. et al. Fibronectin upregulates gelatinase B (MMP-9) and induces coordinated expression of gelatinase A (MMP-2) and its activator MTI-MMP (MMP-14) by human T lymphocyte cell lines. A process repressed through Ras/MAP kinase signaling pathways. Blood 94, 2754-2766 (1999).
24. Brett, J. et al. Tissue distribution of the receptor for advanced glycation endproducts (RAGE): expression in smooth muscle, cardiac myocytes, and neural tissue in addition to the vasculature. Am. J. Pathol. 143,1699-1712 (1993).
25. O'Reilly, M. S. et al. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79, 315-328 (1994).
26. Leder, A., Kuo, A., Cardiff, R. D., Sinn, E. & Leder, P. V-Ha-ras transgene abrogates the initiation step in mouse skin tumorigeneis: effects of phorbol esters and retinoic acid. Proc. Natl Acad. Sci. USA 87, 9178-9182 (1990).
27. Yu, W., Kim, J. & Ossowski, L. Reduction in surface urokinase receptor forces malignant cells into a protracted state of dormancy. J. Cell Biol. 137, 767-777 (1997).
28. Valente, P. et al. TIMP-2 over-expression reduces invasion and angiogenesis and protects B16F10 melanoma cells from apoptosis. Int. J. Cancer 75, 246-253 (1998).
29. Albini, A. et al. A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res. 47, 3239-3245 (1987).
30. Ramamurthy, N. S. & Golab, L. M. Diabetes increases collagenase activity in extracts of rat gingiva and skin. J. Periodont. Res. 18, 23-30 (1983).